Summary

143.80 0.99(0.69%)07/08/2025
DaVita Inc. (DVA)

Key Facts


1 Day1 Week1 Month3 Months6 Months1 Year5 Years
0.69-1.980.00-0.08-6.604.6780.34


Last 730 data points are shown. To view all data, Upgrade to PRO plan!


Fundamental Ratings
CategoryRating
Main RatingB-
Recommended RatingNeutral
DCFStrong Buy
ROEStrong Sell
ROABuy
Debt/EquityStrong Sell
P/ENeutral
P/BStrong Sell


Earnings
  • DVA reported last earnings on 2025-05-12 after the market.
  • An EPS of $2 was observed compared to an estimated EPS of $1.95, resulting in a surprise value of $0.05.
  • A revenue of $3,224 million was observed compared to an estimated revenue of $3,207 million, resulting in a surprise value of $17 Million.


  • Trading Data
    Close143.80
    Open142.20
    High145.88
    Low141.89
    Volume826,675
    Change0.99
    Change %0.69
    Avg Volume (20 Days)857,728
    Volume/Avg Volume (20 Days) Ratio0.96
    52 Week Range134.00 - 179.60
    Price vs 52 Week High-19.93%
    Price vs 52 Week Low7.31%
    Range0.00
    Gap Up/Down-1.69
    Profitibility
    Market Capitalization (Mln)10,512
    Revenue per share163.3974
    Net Income per share10.8307
    Dividend Yield0.0000
    Dividend Share0.00%
    Valuations
    Enterprise Value0.00%
    PE Ratio13.2771
    PB Ratio0.0000
    PTB Ratio0.0000
    Liquidity
    Debt/Equity Ratio0.0000
    Net Debt/EBIDTA Ratio0.0000
    Current Ratio0.0000
    Enterprise Value and Cash Flow
    EV/Sales Ratio0.0000
    EV/EBIDTA Ratio0.0000
    EV/Free Cash Flow Ratio0.0000


    07/02 11:10 EST - zacks.com
    4 Stocks to Watch in a Rapidly Shifting Outpatient Home Health Space
    An aging global population and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry despite the macroeconomic challenges. DGX, EHC, DVA and PNTG are well-poised to gain.
    07/02 10:46 EST - zacks.com
    Why DaVita HealthCare (DVA) is a Top Value Stock for the Long-Term
    Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
    07/01 19:16 EST - zacks.com
    DaVita HealthCare (DVA) Rises As Market Takes a Dip: Key Facts
    In the closing of the recent trading day, DaVita HealthCare (DVA) stood at $146.71, denoting a +2.99% move from the preceding trading day.
    06/16 19:01 EST - zacks.com
    DaVita HealthCare (DVA) Outperforms Broader Market: What You Need to Know
    DaVita HealthCare (DVA) reached $137.84 at the closing of the latest trading day, reflecting a +1.26% change compared to its last close.
    05/30 14:35 EST - prnewswire.com
    DaVita Statement on Government's Kidney Care Choices (KCC) Model Updates
    DENVER , May 30, 2025 /PRNewswire/ -- DaVita, a comprehensive kidney care company, issued the following statement in response to updates this week from the Center for Medicare and Medicaid Innovation (CMMI) related to its Kidney Care Choices (KCC) Model. It can be attributed to Misha Palecek,...
    05/30 10:40 EST - zacks.com
    Here's Why DaVita HealthCare (DVA) is a Strong Value Stock
    Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
    05/27 11:30 EST - seekingalpha.com
    DaVita: International Expansion And Buybacks Will Boost Returns
    International expansion continues with new clinics in Brazil, Ecuador, Chile, and Colombia, supporting long-term growth beyond the US market. DaVita's stock offers a 10% FCF yield, and the share count is decreasing at a fast pace. On top of share buybacks, the company will grow revenues above...
    05/20 16:42 EST - prnewswire.com
    DaVita Inc. Announces Upsize and Pricing of $1 Billion Senior Notes Offering
    DENVER , May 20, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) ("DaVita") announced today the upsize and pricing of its previously announced private offering (the "offering") of its 6.750% senior notes due 2033 (the "2033 notes"). The aggregate principal amount of the 2033 notes offered in the...
    05/20 09:05 EST - prnewswire.com
    DaVita Releases Annual Community Care Report, Highlights Achievements in Corporate Citizenship
    Captures key initiatives achieved in 2024, driving 2025 ESG goals DENVER , May 20, 2025 /PRNewswire/ -- Today, DaVita (NYSE: DVA) published its Community Care report, underpinning its long-standing commitment to corporate citizenship and highlighting strides made towards ambitious Environmental,...
    05/20 08:51 EST - prnewswire.com
    DaVita Inc. Announces Offering of $750 Million Senior Notes
    DENVER , May 20, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) ("DaVita") announced today that it has commenced a private offering (the "offering") of $750 million aggregate principal amount of its senior notes due 2033 (the "2033 notes"), subject to market and other conditions. DaVita intends to...
    05/15 10:50 EST - zacks.com
    Here's Why DaVita HealthCare (DVA) is a Strong Growth Stock
    Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
    05/13 13:15 EST - zacks.com
    DaVita Stock Down Despite Q1 Earnings Beat, Margins Contract
    Strength in revenue per treatment and dialysis patient service revenues drives DVA's first-quarter 2025 performance despite a year-over-year decline in normalized non-acquired treatment.
    05/12 21:41 EST - seekingalpha.com
    DaVita Inc. (DVA) Q1 2025 Earnings Call Transcript
    DaVita Inc. (NYSE:DVA ) Q1 2025 Earnings Conference Call May 12, 2025 5:00 PM ET Company Participants Nic Eliason - Group VP, IR Javier Rodriguez - CEO Joel Ackerman - CFO Conference Call Participants Andrew Mok - Barclays Christian Porter - Bank of America Dean Rosales - Wolfe Research Pito...
    05/12 18:20 EST - zacks.com
    DaVita HealthCare (DVA) Q1 Earnings and Revenues Beat Estimates
    DaVita HealthCare (DVA) came out with quarterly earnings of $2 per share, beating the Zacks Consensus Estimate of $1.75 per share. This compares to earnings of $2.38 per share a year ago.
    05/12 16:51 EST - investopedia.com
    DaVita First-Quarter 2025 Financial Results: Just the Numbers
    Kidney treatment company DaVita (DVA) on Monday afternoon reported first-quarter 2025 financial results. A summary of its key numbers is below.
    05/12 16:05 EST - prnewswire.com
    DaVita Inc. 1st Quarter 2025 Results
    DENVER , May 12, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended March 31, 2025. "Our strong first quarter performance demonstrates the stability and consistency of our operating model" said Javier Rodriguez, CEO of DaVita Inc. "We...
    05/08 12:55 EST - zacks.com
    Can Revenue Cycle Operations Drive DVA Stock Before Q1 Earnings?
    Continued strength in revenue cycle operations is likely to have boosted DaVita's top line in the first quarter despite supply challenges weighing on its performance.